Extracorporeal shock wave therapy in inflammatory diseases: Molecular mechanism that triggers anti-inflammatory action

Current Medicinal Chemistry

Volumn 16, Issue 19, 2009, Pages 2366-2372

  Mariotto, Sofia ^a   de Prati, Alessandra Carcereri ^a   Cavalieri, Elisabetta ^a   Amelio, Ernesto ^b   Marlinghaus, Ernst ^c   Suzuki, Hisanori ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Shock Wave Unit   (Italy)

^c Storz Medical AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANTIINFLAMMATORY ACTIVITY; BONE NECROSIS; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACORPOREAL LITHOTRIPSY; FRACTURE NONUNION; INFLAMMATORY DISEASE; MOLECULAR INTERACTION; NEPHROLITHIASIS; REVIEW; SIGNAL DETECTION; TRANSCRIPTION INITIATION;

ANTI-INFLAMMATORY AGENTS; HIGH-ENERGY SHOCK WAVES; HUMANS; INFLAMMATION; LITHOTRIPSY; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 70349394025     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788682119     Document Type: Review

References (55)

1. Valchanou, V.D.; Michailov, P. High energy shock waves in the treatment of delayed and nonunion of fractures Int. Orthop., 1991, 15, 181.
2. Rompe, J.D.; Zoellner, J.; Nafe, B. Shock wave therapy versus conventional surgery in the treatment of calcifying tendinitis of the shoulder. Clin. Orthop. Relat. Res., 2001, 387, 72.
3. Loew, M., Deacke, W., Kusnierczak, D., Rahmanzadeh, M. & Ewerbeck, V. Shock-wave therapy is effective for chronic calcifying tendinitis of the shoulder. J. Bone Joint Surg., 1999, 81B, 863.
4. Rompe, J.D.; Hope, C.; Kullmer, K.; Heine, J.; Burger, R. Analgesic effect of extracorporeal shock-wave therapy on chronic tennis elbow. J. Bone Joint Surg. Br., 1996, 78, 233.
5. Siebert, W.B. M. Orthopaedics, Springer-Verlag Berlin Ed.: Heidelberg 1998.
6. Filipczynski, L.; Piechocki, M. Estimation of the temperature increase in the focus of a lithotripter for the case of high rate administration. Ultrasound Med. Biol., 1990, 16, 149.
7. Apfel, R.E. Acoustic cavitation: A possible consequence of biomedical uses of ultrasound. Br. J. Cancer Suppl., 1982, 5, 140.
8. Chaussy, C.; Schmiedt, E.; Jocham, D.; Brendel, W.; Forssmann, B.; Walther, V. First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J. Urol., 1982, 127, 417.
9. Karpmann, R.R.; Magee, F.P.; Gruen, T.W.; Mobley, T. The lithotriptor and its potential use in the revision of total hip arthroplasty. Orth. Rev., 1987, 26, 38.
10. Dahmen, G.P.; Meiss, L.; Nam, V.C.; Skruodies, B. Extrakorporale Stosswellentherapie (ESWT) im knochennahem weichteilbereich an der schulter. Extr. Orthopaedica, 1992, 11, 25.
11. Trebinjac, S.; Mujic-Skikic, E.; Ninkovic, E.; Karaikovic, E. Extracorporeal shock wave therapy in orthopaedic diseases. Bosn. J. Basic Med. Sci., 2005, 5, 27.
12. Wang, C.J.; Wang, F.S.; Huang, C.C.; Yang, K.D.; Weng, L.H.; Huang, H.Y. Treatment of osteonecrosis of the femoral head-comparison of extracorporeal shockwave and core decompression and bone grafting. J. Bone Joint Surg. Am., 2005, 87, 2380.
13. Wang, C.J.; Wang, F.S.; Yang, K.D.; Huang, C.C.; Lee, M.S.; Chan, Y.S.; Wang, J.W.; Ko, J.Y. Treatment of osteonecrosis of the hip: Comparison of extracorporeal shockwave with shockwave and alendronate. Arch. Orthop. Trauma Surg., 2008, 128, 901.
14. Buchbinder, R.; Green, S.E.; Youd, J.M.; Assendelft, W.J.; Barnsley, L.; Smidt, N. Systematic review of the efficacy and safety of shock wave therapy for lateral elbow pain. J. Rheumatol., 2006, 33, 1351.
15. Manganotti, P.; Amelio, E. Long-term effect of shock wave therapy on upper limb hypertonia in patients affected by stroke. Stroke, 2005, 36, 1967.
16. Kudo, P.; Dainty, K.; Clarfield, M.; Coughlin, L.; Lavoie, P.; Lebrun, C. Randomized, placebo-controlled, double-blind clinical trial evaluating the treatment of plantar fasciitis with an extracoporeal shockwave therapy (ESWT) device: A North American confirmatory study. J. Orthop. Res., 2006, 24, 115.
17. Buch, M.; Knorr, U.; Fleming, L.; Theodore, G.; Amendola, A.; Bachmann, C.; Zingas, C.; Siebert, W.E. [Extracorporeal shockwave therapy in symptomatic heel spurs. An overview]. Orthopade, 2002, 31, 637.
18. Fukumoto, Y.; Ito, A.; Uwatoku, T.; Matoba, T.; Kishi, T.; Tanaka, H.; Takeshita, A.; Sunagawa, K.; Shimokawa, H. Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron. Artery Dis., 2006, 17, 63.
19. Nishida, T.; Shimokawa, H.; Oi, K.; Tatewaki, H.; Uwatoku, T.; Abe, K.; Matsumoto, Y.; Kajihara, N.; Eto, M.; Matsuda, T.; Yasui, H.; Takeshita, A.; Sunagawa, K. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation, 2004, 110, 3055.
20. Novak, K.F.; Govindaswami, M.; Ebersole, J.L.; Schaden, W.; House, N.; Novak, M.J. Effects of low-energy shock waves on oral bacteria. J. Dent. Res., 2008, 87, 928.
21. Sathishkumar, S.; Meka, A.; Dawson, D.; House, N.; Schaden, W.; Novak, M.J.; Ebersole, J.L.; Kesavalu, L. Extracorporeal shock wave therapy induces alveolar bone regeneration. J. Dent. Res., 2008, 87, 687.
22. Goss, S.A.; Johnston, R.L.; Dunn, F. Comprehensive compilation of empirical ultrasonic properties of mammalian tissues. J. Acoust. Soc. Am., 1978, 64, 423.
23. Seidl, M.; Steinbach, P.; Worle, K.; Hofstadter, F. Induction of stress fibres and intercellular gaps in human vascular endothelium by shock-waves. Ultrasonics, 1994, 32, 397.
24. Seidl, M.; Steinbach, P.; Hofstadter, F. Shock wave induced endothelial damage - in situ analysis by confocal laser scanning microscopy. Ultrasound Med. Biol., 1994, 20, 571.
25. Lokhandwalla, M.; McAteer, J.A.; Williams, J.C., Jr.; Sturtevant, B. Mechanical haemolysis in shock wave lithotripsy (SWL): II. In vitro cell lysis due to shear. Phys. Med. Biol., 2001, 46, 1245.
26. Ichioka, S.; Shibata, M.; Kosaki, K.; Sato, Y.; Harii, K.; Kamiya, A. Effects of shear stress on wound-healing angiogenesis in the rabbit ear chamber. J. Surg. Res., 1997, 72, 29.
27. Dahl, K.N.; Ribeiro, A.J.; Lammerding, J. Nuclear shape, mechanics, and mechanotransduction. Circ. Res., 2008, 102, 1307
28. Moncada, S.; Palmer, R.M.; Higgs, E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 1991, 43, 109.
29. Igarashi, J.; Bernier, S.G.; Michel, T. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J. Biol. Chem., 2001, 276, 12420.
30. Mariotto, S.; Menegazzi, M.; Suzuki, H. Biochemical aspects of nitric oxide. Curr. Pharm. Des., 2004, 10, 1627.
31. Napoli, C.; de Nigris, F.; Williams-Ignarro, S.; Pignalosa, O.; Sica, V.; Ignarro, L.J. Nitric oxide and atherosclerosis: An update. Nitric Oxide, 2006, 15, 265.
32. Siasos, G.; Tousoulis, D.; Siasou, Z.; Stefanadis, C.; Papavassiliou, A.G. Shear stress, protein kinases and atherosclerosis. Curr. Med. Chem., 2007, 14, 1567.
33. Rastaldo, R.; Pagliaro, P.; Cappello, S.; Penna, C.; Mancardi, D.; Westerhof, N.; Losano, G. Nitric oxide and cardiac function. Life Sci., 2007, 81, 779.
34. Mariotto, S.; Cuzzolin, L.; Adami, A.; Del Soldato, P.; Suzuki, H.; Benoni, G. Effect of a new non-steroidal anti-inflammatory drug, nitroflurbiprofen, on the expression of inducible nitric oxide synthase in rat neutrophils. Br. J. Pharmacol., 1995, 115, 225.
35. Mariotto, S.; Cuzzolin, L.; Adami, A.; Del Soldato, P.; Suzuki, H.; Benoni, G. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils. Br. J. Pharmacol., 1995, 114, 1105.
36. Colasanti, M.; Persichini, T.; Menegazzi, M.; Mariotto, S.; Giordano, E.; Caldarera, C.M.; Sogos, V.; Lauro, G.M.; Suzuki, H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J. Biol. Chem., 1995, 270, 26731.
37. Ciampa, A.R.; de Prati, A.C.; Amelio, E.; Cavalieri, E.; Persichini, T.; Colasanti, M.; Musci, G.; Marlinghaus, E.; Suzuki, H.; Mariotto, S. Nitric oxide mediates anti-inflammatory action of extracorporeal shock waves. FEBS Lett., 2005, 579, 6839.
38. Colasanti, M.; Persichini, T. Nitric oxide: An inhibitor of NF-kappaB/ Rel system in glial cells. Brain Res. Bull., 2000, 52, 155.
39. Palomba, L.; Bianchi, M.; Persichini, T.; Magnani, M.; Colasanti, M.; Cantoni, O. Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid. Free Radic. Biol. Med., 2004, 36, 319.
40. Palomba, L.; Persichini, T.; Mazzone, V.; Colasanti, M.; Cantoni, O. Inhibition of nitric-oxide synthase-I (NOS-I)-dependent nitric oxide production by lipopolysaccharide plus interferon-gamma is mediated by arachidonic acid. Effects on NFkappaB activation and late inducible NOS expression. J. Biol. Chem., 2004, 279, 29895.
41. Oldreive, C.; Rice-Evans, C. The mechanisms for nitration and nitrotyrosine formation in vitro and in vivo: Impact of diet. Free Radic. Res., 2001, 35, 215.
42. Moroz, L.L.; Norby, S.W.; Cruz, L.; Sweedler, J.V.; Gillette, R.; Clarkson, R.B. Non-enzymatic production of nitric oxide (NO) from NO synthase inhibitors. Biochem. Biophys. Res. Commun., 1998, 253, 571.
43. Nagase, S.; Takemura, K.; Ueda, A.; Hirayama, A.; Aoyagi, K.; Kondoh, M.; Koyama, A. A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine. Biochem. Biophys. Res. Commun., 1997, 233, 150.
44. Zweier, J.L.; Samouilov, A.; Kuppusamy, P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim. Biophys. Acta, 1999, 1411, 250.
45. Gotte, G.; Amelio, E.; Russo, S.; Marlinghaus, E.; Musci, G.; Suzuki, H. Short-time non-enzymatic nitric oxide synthesis from L-arginine and hydrogen peroxide induced by shock waves treatment. FEBS Lett., 2002, 520, 153.
46. Mariotto, S.; Cavalieri, E.; Amelio, E.; Ciampa, A.R.; de Prati, A.C.; Marlinghaus, E.; Russo, S.; Suzuki, H. Extracorporeal shock waves: From lithotripsy to anti-inflammatory action by NO production. Nitric Oxide, 2005, 12, 89.
47. Fulton, D.; Church, J.E.; Ruan, L.; Li, C.; Sood, S.G.; Kemp, B.E.; Jennings, I.G.; Venema, R.C. Src kinase activates endothelial nitric-oxide synthase by phosphorylating Tyr-83. J. Biol. Chem., 2005, 280, 35943.
48. Garcia-Cardena, G.; Fan, R.; Stern, D.F.; Liu, J.; Sessa, W.C. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem., 1996, 271, 27237.
49. Colasanti, M.; Suzuki, H. The dual personality of NO. Trends Pharmacol. Sci., 2000, 21, 249.
50. Forstermann, U.; Pollock, J.S.; Schmidt, H.H.; Heller, M.; Murad, F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA, 1991, 88, 1788.
51. 2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J. Biol. Chem., 2001, 276, 32663.
52. Davies, P.F.; Zilberberg, J.; Helmke, B.P. Spatial microstimuli in endothelial mechanosignaling. Circ. Res., 2003, 92, 359.
53. Corson, M.A.; James, N.L.; Latta, S.E.; Nerem, R.M.; Berk, B.C.; Harrison, D.G. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ. Res., 1996, 79, 984.
54. 2+- independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ. Res., 1998, 82, 686.
55. Lokhandwalla, M.; Sturtevant, B. Fracture mechanics model of stone comminution in ESWL and implications for tissue damage. Phys. Med. Biol., 2000, 45, 1923.